{"organizations": [], "uuid": "91363b4a19c80c425ed723f4914c4aff579c6295", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180131.html", "section_title": "Archive News &amp; Video for Wednesday, 31 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-qiagen-q4-loss-per-share-018-inclu/brief-qiagen-q4-loss-per-share-0-18-including-items-idUSASB0C3C4", "country": "US", "domain_rank": 408, "title": "BRIEF-Qiagen Q4 Loss Per Share $0.18 Including Items", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.089, "site_type": "news", "published": "2018-02-01T05:24:00.000+02:00", "replies_count": 0, "uuid": "91363b4a19c80c425ed723f4914c4aff579c6295"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-qiagen-q4-loss-per-share-018-inclu/brief-qiagen-q4-loss-per-share-0-18-including-items-idUSASB0C3C4", "ord_in_thread": 0, "title": "BRIEF-Qiagen Q4 Loss Per Share $0.18 Including Items", "locations": [], "entities": {"persons": [{"name": "announ", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "qiagen nv", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "qiagen", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Qiagen Nv:\n* QIAGEN REPORTS RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017, ANNOUNCES STAT-DX ACQUISITION AND NEW $200 MILLION SHARE REPURCHASE\n* Q4 SALES ROSE 8 PERCENT TO $396.9 MILLION * Q4 LOSS PER SHARE $0.18 INCLUDING ITEMS * Q4 ADJUSTED EARNINGS PER SHARE $0.43 * REAFFIRMS 2020 MID-TERM TARGETS * Q4 EARNINGS PER SHARE VIEW $0.40 -- THOMSON REUTERS I/B/E/S\n* FOR 2018, EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE TO BE APPROXIMATELY $1.38-$1.40 CER\n* FOR 2018, QIAGEN EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE EXPECTED TO BE REDUCED TO ABOUT $1.31-1.33 CER\n* ORGANIC GROWTH IN NET SALES IS EXPECTED TO BE ABOUT 6-7% CER FOR 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-01T05:24:00.000+02:00", "crawled": "2018-02-01T15:20:42.005+02:00", "highlightTitle": ""}